Topamax (Topiramate)


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 31.6%
Depression 15.8%
Multiple Sclerosis 15.8%
Diabetic Neuropathy 10.5%
Epilepsy 5.3%
Headache 5.3%
Hypothyroidism 5.3%
Opsoclonus Myoclonus 5.3%
Somnolence 5.3%
Somnolence 15.4%
Grand Mal Convulsion 7.7%
Malaise 7.7%
Maternal Drugs Affecting Foetus 7.7%
Paranoia 7.7%
Respiratory Tract Infection 7.7%
Skin Discomfort 7.7%
Skin Erosion 7.7%
Syncope 7.7%
Tic 7.7%
Ulcer 7.7%
Ventricular Fibrillation 7.7%
Concomitant
Multiple Sclerosis 30.9%
Tuberous Sclerosis 13.8%
Immunodeficiency Common Variable 5.7%
Relapsing-remitting Multiple Sclerosis 5.7%
Complex Partial Seizures 4.9%
Depression 4.9%
Infantile Spasms 4.9%
Product Used For Unknown Indication 4.9%
Gait Disturbance 3.3%
Colonoscopy 2.4%
Diabetes Mellitus 2.4%
Hypogammaglobulinaemia 2.4%
Migraine 2.4%
Narcolepsy 2.4%
Grand Mal Convulsion 1.6%
Hereditary Angioedema 1.6%
Hypertension 1.6%
Pain 1.6%
Plasma Cell Myeloma 1.6%
Acromegaly 0.8%
Vomiting 18.3%
Pain 6.7%
Somnolence 6.7%
Palpitations 5.0%
Pneumonia 5.0%
Upper Respiratory Tract Infection 5.0%
Vision Blurred 5.0%
Visual Impairment 5.0%
Weight Increased 5.0%
White Blood Cell Count Decreased 5.0%
Bradycardia 3.3%
Headache 3.3%
Laceration 3.3%
Nausea 3.3%
Panic Attack 3.3%
Pyrexia 3.3%
Rash 3.3%
Renal Failure 3.3%
Somnambulism 3.3%
Therapeutic Response Decreased 3.3%

Drug Data